These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1166120)

  • 41. Cross-Reactivity of Neutralizing Antibodies among Malignant Catarrhal Fever Viruses.
    Taus NS; Cunha CW; Marquard J; O'Toole D; Li H
    PLoS One; 2015; 10(12):e0145073. PubMed ID: 26658281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cytotoxic T-lymphocyte line propagated from a rabbit infected with sheep associated malignant catarrhal fever.
    Reid HW; Buxton D; Pow I; Finlayson J; Berrie EL
    Res Vet Sci; 1983 Jan; 34(1):109-13. PubMed ID: 6601284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoblotting analysis of the reaction of wildebeest, sheep and cattle sera with the structural antigens of alcelaphine herpesvirus-1 (malignant catarrhal fever virus).
    Herring A; Reid H; Inglis N; Pow I
    Vet Microbiol; 1989 Mar; 19(3):205-15. PubMed ID: 2718352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of experimental subunit vaccines for infectious bovine rhinotracheitis.
    Lupton HW; Reed DE
    Am J Vet Res; 1980 Mar; 41(3):383-90. PubMed ID: 6245609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Observations on two strains of bovine malignant catarrhal fever virus in tissue culture.
    Wibberley G
    Res Vet Sci; 1976 Jul; 21(1):105-7. PubMed ID: 951518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
    Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
    Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epizootology of wildebeest-derived malignant catarrhal fever in an outbreak in the north-western Transvaal: indications of an intermediate host.
    Barnard BJ; van de Pypekamp HE; Griessel MD
    Onderstepoort J Vet Res; 1989 Jun; 56(2):135-9. PubMed ID: 2748134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A microtitre technique for the assay of malignant catarrhal fever virus and neutralising antibody.
    Mushi EZ; Plowright W
    Res Vet Sci; 1979 Sep; 27(2):230-2. PubMed ID: 523811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves.
    Rebelatto MC; Siger L; Hogenesch H
    Res Vet Sci; 2001 Aug; 71(1):9-15. PubMed ID: 11666140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
    Van Oirschot JT
    Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the efficacy of different adjuvants in live stock specific bacterial vaccines for turkeys against Bordetella infection and onset of antibody titers in respect to the age of the turkey poults.
    Glünder G; van der Ven H; Foulman A
    Pol J Vet Sci; 2004; 7(2):77-81. PubMed ID: 15230536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electron microscopic study of the African strain of malignant catarrhal fever virus in bovine cell cultures.
    Castro AE; Daley GG
    Am J Vet Res; 1982 Apr; 43(4):576-82. PubMed ID: 7073076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralising antibodies to wildebeest-derived malignant catarrhal fever virus in African wildlife.
    Hamblin C; Hedger RS
    Comp Immunol Microbiol Infect Dis; 1984; 7(3-4):195-9. PubMed ID: 6099787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Active immunization of cattle with killed vaccines prepared from cell-cultured Rinderpest virus.
    Mirchamsy H; Shafyi A; Bahrami S; Nazari P; Akbarzadeh J
    Res Vet Sci; 1974 Sep; 17(2):242-7. PubMed ID: 4425313
    [No Abstract]   [Full Text] [Related]  

  • 56. [Analysis of symptoms associated with bovine herpesvirus 1 vaccination].
    van Wuijckhuise L; Frankena K; van Oijen MA; Meijer L
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):173-80. PubMed ID: 11285635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protection against Fasciola hepatica in rats with adult fluke antigen in Freund's adjuvant: influence of antigen batch, antigen dose and number of sensitising injections.
    Oldham G
    Res Vet Sci; 1983 Mar; 34(2):240-4. PubMed ID: 6856998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The choice of adjuvants in Mycoplasma vaccines.
    Garba SA; Terry RJ; Adegboye DS; Lamorde AG; Abalaka JA
    Microbios; 1989; 57(230):15-9. PubMed ID: 2661969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The etiology and epidemiology of malignant catarrh--a review].
    Metzler AE; Burri HR
    Schweiz Arch Tierheilkd; 1990; 132(4):161-72. PubMed ID: 2193384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunoglobulin response of rabbits infected with malignant catarrhal fever virus.
    Rossiter PB
    Res Vet Sci; 1982 Jul; 33(1):120-2. PubMed ID: 6982493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.